Schedule 13G ownership disclosure

CARA THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 140755208

Event date: 2025-04-15

Filing-level shares
946,974.00
Percent of class
10.1%
  • Samuel D. Tweardy

    Shares: 946,974.00 · Class: 10.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-011796
Form type
SCHEDULE 13G
Filer
Tvardi Therapeutics, Inc.
CIK
CIK 1346830
Filed
May 02, 2025
Reporting period
Apr 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub